This information is intended only for healthcare professionals resident in the United Kingdom

Prescribing Information (PI) for Emblaveo® (aztreonam/avibactam) Great Britain (GB) and Northern Ireland (NI)​​​

Pfizer Ltd. accepts no responsibility for the content or services of the linked site other than the information relating to Pfizer medicines which it has provided or reviewed

Great Britain

  • Emblaveo (aztreonam/avibactam) 1.5 g/0.5 g powder for concentrate for solution for infusion - PI for GB

Northern Ireland

  • Emblaveo (aztreonam/avibactam) 1.5 g/0.5 g powder for concentrate for solution for infusion - PI for NI 

Emblaveo (aztreonam/avibactam) 1.5 g/0.5 g powder for concentrate for solution for infusion - PI for GB

Emblaveo (aztreonam/avibactam) 1.5 g/0.5 g powder for concentrate for solution for infusion - PI for NI 

PP-A1E-GBR-0026 September 2024